Skip to main content
NoticePayment processing is currently down, so we are not taking new orders right now. Thank you for your patience.
For laboratory research use only. Not for human or veterinary use.
Free UPS Ground on 3+ vials · same business day by 2 PM ET
Neuropeptides

Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia

Medvedev VE, Tereshchenko OE, Israelyan AY, et al. · Zh Nevrol Psikhiatr Im S S Korsakova · 2007
PMID: 18454096
Summary

Clinical comparison study (n=62) of intranasal selank vs medazepam in generalized anxiety disorder and neurasthenia. Endpoints: Hamilton anxiety scale, Zung, CGI; plasma leu-enkephalin.

Read the full citation on PubMed

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

Compounds referenced in this study
  • Selank
    Synthetic tuftsin analog studied in anxiolytic and immunomodulatory research literature.
    View product →
Guides covering this compound
More Neuropeptides citations
Browse the catalog